ArticleCellular and molecular life sciences : CMLS2022

Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy.

Ana Mitrović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.